BrightSpring Health Services Inc. (BTSG)
NASDAQ: BTSG · Services-Home Health Care Services · Louisville, KY
Our rating: Neutral
Neutral reaffirmed at $66.26, moderate conviction, November 2, 2026.
Breaks if: The neutral call turns positive if net margin trends above 2.5% and trailing-twelve-month free cash flow exceeds $500M within the next two quarterly filings — confirming that 28% top-line growth is producing genuine operating leverage. It turns cautious if net margin falls below 0.8% for two consecutive quarters, signaling that reimbursement or labor pressures are consuming the already-thin earnings base, or if year-over-year revenue growth decelerates below 10%, raising the possibility that acquisition-fueled scale gains are not repeatable.
Key figures
| Market value | $12.5B |
|---|---|
| Revenue, last 12 months | $15.3B |
| Net income, last 12 months | $410M |
| Free cash flow, last 12 months | $492M |
| Price to earnings | 30.5× |
| Free cash flow yield | 3.9% |
| Dividend yield | 0.0% |
| Operating margin | 3.4% |
| Return on equity | 20.5% |
| Beta to the S&P 500 | 1.06 |
| Volatility, annualized | 44.9% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $4.2B | 26.4% | $0.45 | $182M |
| June 30, 2026 | $3.9B | 23.0% | $0.38 | $15M |
| March 31, 2026 | $3.6B | 25.6% | $0.67 | $101M |
| December 31, 2025 | $3.6B | 29.3% | $0.35 | $194M |
| September 30, 2025 | $3.3B | 28.2% | $0.26 | $92M |
| June 30, 2025 | $3.1B | 29.1% | $0.13 | $25M |
| March 31, 2025 | $2.9B | 25.9% | $0.14 | $84M |
| December 31, 2024 | $2.7B | 121.6% | $0.09 | $75M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $4.48B: Claude 62%, Gemini 88%, Mistral 78%
- Diluted earnings per share are at least $0.35: Claude 55%, Gemini 89%, Mistral 62%
- Free cash flow for the quarter is at least $0.19B: Claude 45%, Gemini 35%, Mistral 48%
15 ledger entries and 20 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.